BACKGROUND Mucositis is a highly significant, and sometimes dose‐limiting, toxicity of
cancer therapy. The goal of this systematic review was to update the Multinational …

Answer questions and earn CME/CNE Oral complications resulting from cancer and cancer
therapies cause acute and late toxicities that may be underreported, underrecognized, and …

Treatment is complex for patients with head and neck (H&N) cancers with specific site of
disease, stage, and pathologic findings guiding treatment decision-making. Treatment …

Oral mucositis is a clinically important and sometimes dose-limiting complication of cancer
therapy. Mucositis lesions can be painful, affect nutrition and quality of life, and have a …

Oral mucositis is a toxic side effect of non-surgical cancer treatments: chemotherapy and
radiotherapy, which strongly impair quality of life and can not only cause strong pain, but …

Purpose: To study the risk, outcomes, and costs of radiation-induced oral mucositis (OM)
among patients receiving radiotherapy (RT) to head and neck primary cancers. Methods and …

Oral mucositis induced by conventional cytotoxic cancer therapies is a common and
significant clinical problem in oncology. Mucositis symptoms, which include severe pain …

Background: Treatment breaks during radiation for locally advanced Head and Neck
Squamous Cell Carcinoma (HNSCC) is one of the important factors affecting the loco …

Background Objective was to determine whether prophylactic low level laser therapy (LLLT)
reduces the risk of severe mucositis as compared to placebo or no therapy. Methods …

An estimated 1.6 million people receive cancer therapy in the United States each year and
worldwide numbers are much higher. 1 Although advancements in cancer therapy improved …